Effects of aminooxyacetic acid and baclofen on the catalepsy and on the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats.
D000085:Acetates / Q000494:pharmacology*; D000613:Aminobutyrates / Q000494:pharmacology*; D000625:Aminooxyacetic Acid / Q000494:pharmacology*; D000818:Animals; D001418:Baclofen / Q000494:pharmacology*; D001923:Brain Chemistry; D002375:Catalepsy / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D006220:Haloperidol / Q000494:pharmacology*; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D008032:Limbic System / Q000378:metabolism*; D051381:Rats; D014443:Tyrosine / Q000031:analogs & derivatives / Q000378:metabolism; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D000085:Acetates; D000613:Aminobutyrates; D000625:Aminooxyacetic Acid; D014443:Tyrosine; D005680:gamma-Aminobutyric Acid; D001418:Baclofen; D006220:Haloperidol; D004298:Dopamine; D006719:Homovanillic Acid